The current global economic climate presents a challenging environment for all industries right now, and healthcare is far from immune. Drug-makers are facing up to their inevitable patent cliffs and the rise of generic products, while all players in the ecosystem are racing to adjust to technological and demographic shifts including older populations, ever-increasing access to [...]





